INFECTION: Proof of principle for effectiveness of a gonorrhoea vaccine

    loading  Checking for direct PDF access through Ovid

Abstract

Antimicrobial resistance in Neisseria gonorrhoeae compromises gonorrhoea treatment globally and vaccines might be the only sustainable solution for gonorrhoea control. A new study for the first time provides a proof of principle for protection with ˜31% effectiveness against gonorrhoea, owing to cross-protection by the outer membrane vesicle Neisseria meningitidis serogroup B vaccine (MeNZB).

Refers to Petousis-Harris, H. et al. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancethttp://dx.doi.org/10.1016/S0140-6736(17)31449-6 (2017)

Related Topics

    loading  Loading Related Articles